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A
lthough depression symptoms are associated with an
increased risk of recurrent cardiovascular disease in
patients who have experienced an acute coronary
syndrome (ACS) event, the exact mechanisms remain poorly
understood. Inflammation has been suggested to be a
mechanism in the depression–ACS prognosis link, as raised
concentrations of inflammatory biomarkers, especially
C reactive protein (CRP), are associated with recurrent
cardiovascular events.1 In the few studies that have examined
the relation between depression status and CRP concentra-
tions after an ACS event, depression and CRP concentrations
were assessed 2–6 months after the index ACS event, when
the rate of depression remission would already be relatively
high.2–4 The objective of this study was to examine the
relation between the course of depression and CRP concen-
trations after an ACS event.
METHODS
Patients were enrolled from an ancillary study of COPES
(Coronary Psychosocial Patient Evaluation Study), a multi-
site, observational cohort study designed to investigate the
aetiology and naturalistic course of depressive symptoms in
the three-month period after an ACS event. Patients were
eligible for inclusion in COPES if they had been hospitalised
for an ACS event (either acute myocardial infarction with or
without ST segment elevation or unstable angina) and scored
between 0 and 4 (indicative of no depressive symptoms) or
> 10 (at least mild depressive symptoms) on the Beck
Depression Inventory (BDI) within one week after the index
ACS event. The BDI is a self-report measure of depressive
symptom severity, and a score of > 10 is associated with
increased mortality risk after an ACS event.5 The BDI was
readministered three months after enrolment.
Of the 275 patients enrolled in the COPES parent study
between May 2003 and May 2005, 162 (58.9%) consented to
a substudy in which blood was drawn to assess CRP
concentrations at baseline and at the three-month follow
up. Substudy participants did not differ from non-partici-
pants on age, sex, baseline depression score and several
clinical variables (p . 0.20) (table 1 lists the variables). Of
the 162 participants, 59 (36.4%) did not get their blood
drawn at three months: 50 patients (30.9%) were lost to
follow up, 5 (3.0%) declined follow up and 4 (2.5%) died.
As the primary objective of this study was to determine the
relation between CRP concentration and depression remis-
sion status over time, patients were classified into three
comparison groups: persistently depressed (BDI score> 10 at
baseline and after three months), remittently depressed (BDI
score > 10 at baseline and , 10 after three months) and
persistently non-depressed (BDI score 0–4 at baseline and
, 10 after three months).
After centrifugation, serum samples were stored in aliquot
portions at270 C˚ until they were shipped to a core laboratory
(Specialty Laboratories, Valencia, California, USA) for analy-
sis of high sensitivity CRP concentrations. Concentrations of
CRP were determined by turbidimetry (Bayer Diagnostics,
Leverkusen, Germany). We divided CRP concentrations into
two categories: ( 3 mg/l and . 3 mg/l as previously
described.1 A cut off of 3 mg/l identifies a group at increased
risk for recurrent events and death after an ACS event.1
Written informed consent was obtained from all participants,
and the study was approved by the research ethics
committees of the three university-affiliated hospitals from
which the participants were recruited (Mount Sinai Hospital,
New York, New York; University of Medicine & Dentistry of
New Jersey, New Jersey; and Yale–New Haven Hospital, New
Haven, Connecticut, USA).
Differences in baseline characteristics between groups and
differences in CRP concentrations in depression groups were
analysed by univariate analyses of variance or x2 analyses. To
test for the impact of potential confounders that were
specified a priori, a hierarchical logistic regression analysis
was conducted. We used two-tailed tests of significance and
SPSS statistical software (V.12.0; SPSS Inc, Chicago, Illinois,
USA).
RESULTS
Of 103 patients, 58 (56.3%) were depressed (BDI score > 10)
and 45 (43.7%) were non-depressed (BDI score ( 4) at
baseline. After three months, 21 patients (20.4%) were
classified as persistently depressed, 24 (23.3%) as remittently
depressed and 55 (53.4%) as persistently non-depressed.
Three patients (2.9%) became newly depressed at follow up
(non-depressed at baseline and depressed at three months).
As we were primarily interested in studying the relation
between depression remission status and CRP concentra-
tions, these three patients were omitted from the analysis.
Thus, the final study sample comprised 100 patients.
Among the three groups (persistently depressed, remit-
tently depressed and persistently non-depressed), the per-
centages of women and patients with a history of
hypercholesterolaemia were significantly higher in the
remittently depressed group than in the persistently non-
depressed group (table 1). The groups did not otherwise
differ significantly in clinical characteristics.
At baseline, no significant differences were found in CRP
concentrations among the three groups (95.2%, 79.2%, and
72.7% respectively, p = 0.10). At three months (fig 1),
persistently depressed patients were more likely to have
raised CRP concentrations than were the persistently non-
depressed group (p = 0.002). Compared with the remit-
tently depressed patients, the persistently non-depressed
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group also were less likely to have raised CRP concentrations,
although this difference was not significant (p = 0.08). CRP
concentrations did not differ significantly between the
remittently and persistently depressed patients (p = 0.36).
The differences in raised CRP concentrations among the three
groups remained unchanged after controlling for age, sex,
body mass index, diabetes mellitus, hypertension, hyperch-
olesterolaemia, history of congestive heart failure, Killip class
and statin use at any time during the three months after the
index ACS event.
DISCUSSION
Our study is the first to assess depression and CRP
concentrations within one week after an ACS event and
again after three months. We found that depression remis-
sion status three months after an ACS event was significantly
associated with raised CRP concentrations, independent of
several possible confounders.
To our knowledge, three other studies have examined the
relation between depression and inflammatory biomarker
concentrations after an ACS event.2–4 Only one study has
shown that depressive symptoms are significantly associated
with increased concentrations of CRP, independent of several
confounders.4 As these cross-sectional studies assessed
depression and CRP concentrations about 2–6 months after
the index ACS event, discrepant results may be explained by
the inclusion of patients with new-onset depression in the
depressed group and those with remittent depression in the
non-depressed group.
Spontaneous improvement in BDI scores after an ACS
hospitalisation is associated with a significantly greater
survival of patients with at least mild baseline depressive
symptoms than of patients whose BDI scores remain raised.5
Our data suggest a dose–response-like relation between
depression remission status after an ACS event and raised
CRP concentrations. Thus, the lower survival rate observed
among persistently depressed patients may be associated
with raised CRP concentrations and, conversely, the higher
survival rate observed among patients with remittent
depression may be associated with lower CRP concentrations.
Our study has potential limitations. Although these
associations are plausible, our study cannot discriminate
between the several possible causal directions between
depression and inflammation. The study is also limited by
the size of the cohort and the lack of information about
antidepressant use. Further research should be conducted to
confirm our findings and to examine whether raised CRP
concentrations mediate the relation between depression
course and the recurrence of cardiovascular events.
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Table 1 Group characteristics
Depression category
p ValuePersistent (n = 21) Remittent (n = 24)
Persistent non-
depression (n = 55)
Mean age (years) 59.1 (SD 16.4) 60.3 (SD 11.5) 60.5 (SD 10.6) 0.91
Women 52.4% 75.0%* 36.4% 0.01
Current smoker 23.8% 29.2% 12.7% 0.19
Diabetes mellitus 14.3% 33.3% 21.8% 0.30
History of hypertension 71.4% 65.2% 67.9% 0.91
History of hypercholesterolaemia 65.0% 87.0%* 67.9% 0.01
Overweight (BMI 25–29.9 kg/m2) 30.0% 50.0% 41.8% 0.53
Obese (BMI >30 kg/m2) 50.0% 37.5% 38.2% 0.81
History of CHF 9.5% 0 5.6% 0.34
Killip class >II 9.5% 4.2% 3.2% 0.57
Statin use at baseline 40.0% 62.5% 41.5% 0.19
Statin use at any time during the 3
months of follow up
81.0% 87.5% 90.9% 0.49
*Significantly different from the persistently non-depressed group (p,0.05); assessed by self-report at baseline.






























Figure 1 Relation of depression remission status and raised C reactive
protein (CRP) concentrations three months after an acute coronary
syndrome event. The grey area indicates raised CRP concentrations
(. 3 mg/l) and the white area, not raised CRP concentrations
( 3 mg/l). p = 0.002 for comparison between persistently depressed
and persistently non-depressed patients; p = 0.08 for comparison
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Resolution of dynamic left ventricular outflow tract obstruction caused by retained native leaflets
following mitral valve replacement using medical treatment
A
72-year-old woman with atrial fibrilla-
tion underwent surgical treatment for
severe mitral regurgitation and wor-
sening breathlessness. Previous echocardio-
graphy showed preserved systolic function
with prominent septal knuckle. Coronary
angiography identified two vessel coronary
disease.
Operative findings revealed an essentially
unremarkable mitral valve with dilated
annulus and dilated poorly contractile left
ventricle. A Carpentier Edwards prosthesis
was inserted leaving the entire mitral appa-
ratus intact to preserve ventricular function.
Severe tricuspid regurgitation required
annuloplasty and two bypass grafts were
placed. Haemodynamic instability postopera-
tively was unresponsive to inotropic therapy
and subsequent echocardiography showed
severe left ventricular outflow tract (LVOT)
obstruction caused by prominent septal
knuckle and systolic anterior motion of the
retained anterior mitral valve leaflet (panels
A and B). Peak LVOT gradient was
120 mm Hg and the patient remained
breathless on minimal exertion. Because
the patient was frail she was managed
medically by cessation of digoxin and gra-
dual introduction of bisoprolol. Within two
months the LVOT gradient reduced to
8 mm Hg with only mild symptomatic lim-
itation (panels C and D). She remains well
and recently attended an outpatient review
at six months post-surgery.
LVOT obstruction is recognised after mitral
valve replacement with chordal preservation
and a very high mortality has previously
been reported. Inotropes may exacerbate
obstruction by reducing left ventricular
cavity size. Intraoperative transoesophageal
echocardiography is advisable following
valve replacement, particularly in cases of
septal hypertrophy where the anterior
mitral valve leaflet should be excised.
This case demonstrates successful medical






Panels A and B: Apical long axis view showing Carpentier Edwards mitral prosthesis with retained
native valve and septal knuckle during diastole (A) and during systole (B) where there is dynamic left
ventricular outflow tract obstruction caused by systolic anterior motion of the native anterior mitral
valve leaflet. Panels C and D: Apical five chamber view showing continuous wave Doppler trace of
peak LVOT gradient mean 120 mm Hg (patient in atrial fibrillation) post-surgery (C) and
approximately 8 mm Hg at two months after introduction of a b blocker (D).
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